Affordable Access

Publisher Website

Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study

Authors
Journal
Journal of the American Academy of Dermatology
0190-9622
Publisher
Elsevier
Publication Date
Volume
59
Issue
4
Identifiers
DOI: 10.1016/j.jaad.2008.05.031
Disciplines
  • Medicine

Abstract

Background The use of light-emitting diode light offers practical advantages in photodynamic therapy (PDT) with topical methyl-aminolevulinate (MAL) for management of actinic keratoses (AK). Objective We sought to evaluate the efficacy of MAL PDT using red light-emitting diode light. Methods We conducted a multicenter, double-blind, randomized study. A total of 49 patients with 363 AK lesions had 16.8% MAL cream applied under occlusion for 3 hours, and 47 patients with 360 AK lesions had vehicle cream similarly applied. The lesions were then illuminated (630 nm, light dose 37 J/cm 2) with repeated treatment 1 week later. Complete lesion and patient (all lesions showing complete response) response rates were evaluated 3 months after last treatment. Results MAL PDT was superior ( P < .0001) to vehicle PDT with respect to lesion complete response (86.2% vs 52.2%, odds ratio 6.9 [95% confidence interval 4.7-10.3]) and patient complete response (59.2% vs 14.9%, odds ratio 13.2 [95% confidence interval 4.1-43.1]). Limitations The study population may not be representative of all patients with AK. Conclusion MAL PDT using red light-emitting diode light is an appropriate treatment alternative for multiple AK lesions.

There are no comments yet on this publication. Be the first to share your thoughts.